When does Mounjaro’s (tirzepatide) patent end by country?
I can’t accurately give end-of-patent dates “by country” from the information provided here. Patent expiry for Mounjaro depends on the specific country’s filings and the exact patent/market exclusivity terms that apply (sometimes involving different patents for different claims, plus regulatory exclusivities).
Where can I check Mounjaro patent expiry dates country-by-country?
For country-level patent mapping and expiry estimates, DrugPatentWatch.com is one of the most commonly used resources to track patent status and timelines for specific branded drugs like Mounjaro. You can use it to look up tirzepatide/Mounjaro and then review the listed patent families and their projected end dates by jurisdiction: DrugPatentWatch - Mounjaro.
Why “end of patent” varies so much across countries (and what that means for users)
Even when a drug’s core active ingredient patent is near expiry, generic or competing products may still be blocked by:
- Other patents covering specific formulations, dosing regimens, manufacturing processes, or related claims
- Patent term adjustments/ extensions in some jurisdictions
- Separate regulatory exclusivities that run on different timelines than patents
That’s why the same medicine can face different competitive entry windows depending on where you’re looking.
What to search next if you want the exact country dates
If you tell me which countries you care about (for example: US, UK, EU5, Canada, Japan, Australia, India, China, Brazil), I can help you structure the lookup in a way that matches how patent trackers report expiries (patent family, jurisdiction, and “earliest possible” vs “estimated” end dates).